News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Ekman Lars
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/19/2023 |
4
| Ekman Lars (Director) has filed a Form 4 on PROTHENA CORP PUBLIC LTD CO|
Txns:
| Granted 15,000 options to buy
@ $76, valued at
$1.1M
|
|
| 01/05/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/30/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/29/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/27/2022 |
4
| Ekman Lars (Director) has filed a Form 4 on PROTHENA CORP PUBLIC LTD CO|
Txns:
| Granted 15,000 options to buy
@ $25.6, valued at
$384k
|
|
| 06/28/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/17/2021 |
4
| Ekman Lars (Director) has filed a Form 4 on PROTHENA CORP PUBLIC LTD CO|
Txns:
| Disposed/sold 15,000 options to buy
@ $34.04, valued at
$510.6k
Granted 9,803 options to buy
@ $22.85, valued at
$224k
Disposed/sold 15,000 options to buy
@ $42.5, valued at
$637.5k
Granted 8,426 options to buy
@ $22.85, valued at
$192.5k
Disposed/sold 12,000 options to buy
@ $56.23, valued at
$674.8k
Granted 6,315 options to buy
@ $22.85, valued at
$144.3k
|
|
| 07/15/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/30/2020 |
4
| Ekman Lars (Director) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.|
Txns:
| Granted 2,550 shares
@ $0
Granted 4,250 options to buy
@ $76.58, valued at
$325.5k
|
|
| 05/22/2020 |
4
| Ekman Lars (Director) has filed a Form 4 on Prothena Corp plc|
Txns:
| Granted 17,500 options to buy
@ $11.33, valued at
$198.3k
|
|
| 12/17/2019 |
4
| Ekman Lars (Director) has filed a Form 4 on Spark Therapeutics, Inc.|
Txns:
| Unknown transaction of 3,000 shares
@ $114.5, valued at
$343.5k
Disposed/sold 4,000 options to buy
@ $81.53, valued at
$326.1k
Disposed/sold 4,000 options to buy
@ $50.93, valued at
$203.7k
Disposed/sold 6,000 options to buy
@ $56.22, valued at
$337.3k
Disposed/sold 37,203 options to buy
@ $3.45, valued at
$128.4k
|
|
| 11/13/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/07/2019 |
4
| Ekman Lars (Director) has filed a Form 4 on AMARIN CORP PLC\UK|
Txns:
| Sold 6,400 shares
@ $18.0047, valued at
$115.2k
Exercised 6,400 options to buy
@ $14.4, valued at
$92.2k
|
|
| 09/05/2019 |
4
| Ekman Lars (Director) has filed a Form 4 on AMARIN CORP PLC\UK|
Txns:
| Sold 91,016 shares
@ $15.0053, valued at
$1.4M
Exercised 13,500 options to buy
@ $5.58, valued at
$75.3k
Exercised 25,845 options to buy
@ $3.06, valued at
$79.1k
Exercised 51,671 options to buy
@ $3.21, valued at
$165.9k
|
|
| 06/28/2019 |
4
| Ekman Lars (Director) has filed a Form 4 on SOPHIRIS BIO INC.|
Txns:
| Granted 20,000 options to buy
@ $0.7782, valued at
$15.6k
|
|
| 06/13/2019 |
4
| Ekman Lars (Director) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.|
Txns:
| Granted 3,000 shares
@ $0
Granted 5,000 options to buy
@ $58.74, valued at
$293.7k
|
|
| 06/03/2019 |
4
| Ekman Lars (Director) has filed a Form 4 on Spark Therapeutics, Inc.|
Txns:
| Exercised 1,500 restricted stock units
@ $0 |
|
| 05/24/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/21/2019 |
4
| Ekman Lars (Director) has filed a Form 4 on AMARIN CORP PLC\UK|
Txns:
| Granted 10,431 options to buy
@ $16.83, valued at
$175.6k
Granted 8,023 restricted stock units
@ $0 |
|
| 03/06/2019 |
4
| Ekman Lars (Director) has filed a Form 4 on AMARIN CORP PLC\UK|
Txns:
| Sold 98,677 shares
@ $21.1607, valued at
$2.1M
Sold 36,700 shares
@ $21.712, valued at
$796.8k
Exercised 19,584 options to buy
@ $1.03, valued at
$20.2k
Exercised 6,390 options to buy
@ $1.87, valued at
$11.9k
Exercised 28,500 options to buy
@ $1.87, valued at
$53.3k
Exercised 35,258 options to buy
@ $2.19, valued at
$77.2k
Exercised 17,358 options to buy
@ $2.5, valued at
$43.4k
Exercised 28,287 options to buy
@ $2.5, valued at
$70.7k
|
|
| 01/11/2019 |
4
| Ekman Lars (Director) has filed a Form 4 on AMARIN CORP PLC\UK|
Txns:
| Sold 21,200 shares
@ $14.9244, valued at
$316.4k
Sold 7,247 shares
@ $15.9622, valued at
$115.7k
Sold 48,711 shares
@ $17.2885, valued at
$842.1k
Sold 55,762 shares
@ $18.1606, valued at
$1M
Sold 7,496 shares
@ $18.6236, valued at
$139.6k
Exercised 100,416 options to buy
@ $1.03, valued at
$103.4k
|
|
| 10/02/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/28/2018 |
4
| Ekman Lars (Director) has filed a Form 4 on SOPHIRIS BIO INC.|
Txns:
| Granted 20,000 options to buy
@ $2.91, valued at
$58.2k
|
|
| 06/20/2018 |
4
| Ekman Lars (Director) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.|
Txns:
| Granted 3,000 shares
@ $0
Granted 5,000 options to buy
@ $80.69, valued at
$403.5k
|
|
| 05/31/2018 |
4
| Ekman Lars (Director) has filed a Form 4 on Spark Therapeutics, Inc.|
Txns:
| Granted 4,000 options to buy
@ $81.53, valued at
$326.1k
Granted 1,500 restricted stock units
@ $0
Exercised 1,500 restricted stock units
@ $0 |
|
| 05/18/2018 |
4
| Ekman Lars (Director) has filed a Form 4 on Prothena Corp plc|
Txns:
| Granted 12,000 options to buy
@ $16.43, valued at
$197.2k
|
|
| 06/22/2017 |
4
| Ekman Lars (Director) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.|
Txns:
| Granted 1,875 shares
@ $0
Granted 3,750 options to buy
@ $65.66, valued at
$246.2k
|
|
| 06/02/2017 |
4
| Ekman Lars (Director) has filed a Form 4 on Spark Therapeutics, Inc.|
Txns:
| Granted 4,000 options to buy
@ $50.93, valued at
$203.7k
Granted 1,500 restricted stock units
@ $0 |
|
|
|
|